Latest News

t Intranasal Epinephrine Should Be Prescribed with Confidence, Editorial Encourages / image credit ©kalpis/stock.adobe.com
Intranasal Epinephrine Should Be Prescribed with Confidence, Editorial Encourages

July 25th 2025

Clinical skepticism about the parity in effectiveness of epinephrine delivered via nasal spray vs autoinjector is rooted in fixed assumptions that bear examination, authors say.

Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis
Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis

July 21st 2025

FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions
FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions

June 17th 2025

Study of Intranasal Epinephrine Powder (NS002) Published in Prestigious International Journal, Nasus Pharma Ltd Says / image credit ©MQ-Illustrations/stock.adobe.com
Phase 2 Dose-Finding Study of Intranasal Epinephrine Powder (NS002) Supports Development for Regulatory Submission

June 3rd 2025

Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose / image credit: ©New Africa/AdobeStock
Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose

March 28th 2025

Latest CME Events & Activities
© 2025 MJH Life Sciences

All rights reserved.